CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 1 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,927
-26.2%
12,4300.0%0.00%
Q2 2023$17,526
-11.3%
12,4300.0%0.00%
Q1 2023$19,764
+8.9%
12,4300.0%0.00%
Q4 2022$18,148
-66.4%
12,4300.0%0.00%
Q3 2022$54,000
-85.7%
12,430
-84.3%
0.00%
Q1 2022$377,000
+19.7%
79,118
-8.1%
0.00%
Q4 2021$315,000
-54.4%
86,0600.0%0.00%
Q3 2021$691,000
-27.3%
86,060
+2.7%
0.00%
Q2 2021$951,00083,7920.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$717,2970.22%
Aisling Capital Management LP 288,571$300,1140.12%
BVF INC/IL 3,614,662$3,759,2480.10%
TRUST CO OF TOLEDO NA /OH/ 33,213$34,5420.01%
MAI Capital Management 397,670$413,5770.01%
Laurion Capital Management LP 698,000$725,9200.00%
RP Management, LLC 3,700$3,8480.00%
UNITED BANK 20,000$20,8000.00%
BOURGEON CAPITAL MANAGEMENT LLC 7,500$7,8000.00%
XTX Topco Ltd 12,084$12,5670.00%
View complete list of VIRACTA THERAPEUTICS INC shareholders